A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. [electronic resource]
Producer: 20190131Description: 207-212 p. digitalISSN:- 2049-4408
- Adult
- Aged
- Aged, 80 and over
- Antifibrinolytic Agents -- therapeutic use
- Arthroplasty, Replacement, Hip
- Blood Loss, Surgical -- prevention & control
- Bone Cements
- Cementation
- Chemoprevention
- Double-Blind Method
- Factor Xa Inhibitors -- therapeutic use
- Female
- Hematologic Agents -- therapeutic use
- Hip Joint -- surgery
- Humans
- Joint Diseases -- surgery
- Male
- Middle Aged
- Prospective Studies
- Rivaroxaban -- therapeutic use
- Tranexamic Acid -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.